Smith & Nephew plc (SNN) Stock Price

SNNStock

$29.06−20.02%52W

Market Cap$12.16B

P/E19.42x

PEG Ratio1.11

Div yield2.95%

Beta1.02

SNN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-24.00%

Price vs S&P 500 (4W)6.21%

PEG Ratio1.11

VGM Score60.86

P/E Ratio (Annual)19.42x

Indicated Dividend Yield (Annual)2.95%

P/CF (Annual)9.44x

Book Value / Share (Quarterly)$5.91

P/TBV (Annual)3.17x

Indicated Dividend (Annual)$29.37

Revenue Growth (3Y)5.73%

Cash Flow / Share (Quarterly)$0.98

Payout Ratio (TTM)52.44%

Price vs S&P 500 (YTD)-23.40%

Gross Margin (TTM)68.21%

Net Profit Margin (TTM)10.08%

EPS (TTM)$0.74

10-Day Avg Trading Volume1.98M

EPS Excl Extra (TTM)$0.74

Revenue Growth (5Y)6.21%

EPS (Annual)$0.72

Dividend / Share (Annual)$0.38

ROI (Annual)7.25%

Gross Margin (Annual)68.25%

Net Profit Margin (5Y Avg)7.26%

Cash / Share (Quarterly)$0.86

P/E Basic Excl Extra (TTM)19.11x

Revenue Growth QoQ (YoY)4.59%

EPS Growth (5Y)6.98%

P/E Normalized (Annual)19.42x

ROA (Last FY)5.98%

Revenue Growth TTM (YoY)5.99%

EBITD / Share (TTM)$1.15

ROE (5Y Avg)7.67%

Operating Margin (TTM)12.90%

Cash Flow / Share (Annual)$1.00

P/B Ratio2.34x

P/B Ratio (Quarterly)2.49x

Net Income / Employee (Annual)$36,800

EV / Revenue (TTM)2.41x

Net Interest Coverage (TTM)4.80x

ROA (TTM)5.92%

EPS Growth QoQ (YoY)5.71%

EV / EBITDA (TTM)15.30x

EPS Incl Extra (Annual)$0.72

Current Ratio (Annual)2.57x

Quick Ratio (Quarterly)1.11x

3-Month Avg Trading Volume2.16M

52-Week Price Return-20.02%

EV / Free Cash Flow (Annual)17.80x

P/E Incl Extra (TTM)19.11x

Revenue / Employee (TTM)$370,900

Tangible BV / Share (Quarterly)$4.65

P/S Ratio (Annual)1.97x

Asset Turnover (Annual)0.59x

52-Week High$1426.50

Operating Margin (5Y Avg)10.58%

EPS Excl Extra (Annual)$0.72

CapEx CAGR (5Y)-0.46%

Tangible BV CAGR (5Y)3.05%

26-Week Price Return-14.10%

Quick Ratio (Annual)1.18x

13-Week Price Return-5.78%

Total Debt / Equity (Annual)0.63x

Current Ratio (Quarterly)2.14x

Enterprise Value$15.17B

Revenue / Share Growth (5Y)6.31%

Asset Turnover (TTM)0.59x

Book Value / Share Growth (5Y)0.64%

Revenue / Employee (Annual)$362,800

Inventory Turnover (Annual)0.87x

Pretax Margin (Annual)12.64%

Cash / Share (Annual)$0.66

3-Month Return Std Dev27.51%

Gross Margin (5Y Avg)70.14%

Net Income / Employee (TTM)$37,400

EBITDA CAGR (5Y)14.32%

EBITDA Interim CAGR (5Y)10.41%

ROE (Last FY)11.82%

Net Interest Coverage (Annual)8.60x

EPS Basic Excl Extra (Annual)$0.72

P/FCF (TTM)14.19x

Receivables Turnover (TTM)4.31x

EV / Free Cash Flow (TTM)17.74x

Total Debt / Equity (Quarterly)0.73x

EPS Incl Extra (TTM)$0.74

Receivables Turnover (Annual)5.57x

ROI (TTM)7.22%

Dividend Growth Rate (5Y)0.41%

P/S Ratio (TTM)1.93x

Pretax Margin (5Y Avg)8.44%

Revenue / Share (Annual)$7.06

Tangible BV / Share (Annual)$5.19

Forward P/E10.49x

Free OCF CAGR (5Y)11.61%

Price vs S&P 500 (52W)-35.55%

P/E Ratio (TTM)19.11x

EPS Growth TTM (YoY)31.68%

Year-to-Date Return-12.43%

5-Day Price Return4.48%

EPS Normalized (Annual)$0.72

ROA (5Y Avg)3.93%

Net Profit Margin (Annual)10.14%

Month-to-Date Return7.48%

Cash Flow / Share (TTM)$0.75

EBITD / Share (Annual)$1.18

EPS Growth (3Y)41.07%

Operating Margin (Annual)12.88%

LT Debt / Equity (Annual)0.57x

P/CF (TTM)9.06x

ROI (5Y Avg)4.77%

P/E Excl Extra (TTM)19.11x

LT Debt / Equity (Quarterly)0.59x

EPS Basic Excl Extra (TTM)$0.74

P/TBV (Quarterly)3.16x

Payout Ratio (Annual)52.80%

P/B Ratio (Annual)2.64x

Dividend / Share (TTM)$0.38

Inventory Turnover (TTM)0.87x

Pretax Margin (TTM)12.65%

Book Value / Share (Annual)$6.22

Price vs S&P 500 (13W)-8.46%

Net Margin Growth (5Y)0.64%

Dividend Yield (TTM)2.74%

Beta1.02x

P/FCF (Annual)14.24x

Revenue / Share (TTM)$7.32

ROE (TTM)12.13%

52-Week Low$980.40

vGradeB

gGradeC

mGradeC

vgmGradeB

SNN Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.79

3.71

3.63

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Smith & Nephew plc

Smith & Nephew is a UK-based medical device company with three core segments: orthopedic devices (41% of revenue), sports medicine and arthroscopic technologies (30%), and advanced wound care (29%). The company generates over half its revenue from North America, with the remainder split between developed and emerging markets.